American Healthcare REIT, Inc. (AHR) Revenue History
Annual and quarterly revenue from 2016 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AHR Revenue Growth
Revenue Breakdown (FY 2024)
AHR's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
AHR Revenue Analysis (2016–2024)
As of May 7, 2026, American Healthcare REIT, Inc. (AHR) generated trailing twelve-month (TTM) revenue of $2.20 billion, reflecting solid growth of +9.4% year-over-year. The most recent quarter (Q3 2025) recorded $572.9 million in revenue, up 5.6% sequentially.
Looking at the longer-term picture, AHR's 5-year compound annual growth rate (CAGR) stands at +11.1%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $2.07 billion in 2024, representing a new all-time high.
Revenue diversification analysis shows AHR's business is primarily driven by Resident Fees and Services (100%). With over half of revenue concentrated in Resident Fees and Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Real Estate sector peers including WELL (+38.3% YoY), VTR (+20.7% YoY), and HR (-7.4% YoY), AHR has underperformed the peer group in terms of revenue growth. Compare AHR vs WELL →
AHR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $2.2B | +9.4% | +11.1% | 6.6% | ||
| $10.7B | +38.3% | +18.4% | 3.3% | ||
| $5.8B | +20.7% | +9.0% | 14.2% | ||
| $1.2B | -7.4% | +9.9% | 8.0% | ||
| $2.8B | +2.7% | +11.4% | 19.3% | ||
| $1.2B | +14.2% | +6.1% | 62.6% |
AHR Historical Revenue Data (2016–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $2.07B | +11.4% | $416.8M | 20.1% | $136.8M | 6.6% |
| 2023 | $1.86B | +14.9% | $356.8M | 19.2% | $76.7M | 4.1% |
| 2022 | $1.62B | +28.0% | $336.0M | 20.8% | $90.6M | 5.6% |
| 2021 | $1.26B | +6.7% | $182.0M | 14.4% | $138.8M | 11.0% |
| 2020 | $1.18B | -3.0% | $158.6M | 13.4% | $131.6M | 11.1% |
| 2019 | $1.22B | +7.9% | $219.3M | 18.0% | $189.6M | 15.5% |
| 2018 | $1.13B | +7.8% | $207.6M | 18.3% | $179.1M | 15.8% |
| 2017 | $1.05B | +7.0% | $211.6M | 20.2% | $179.4M | 17.1% |
| 2016 | $980.3M | - | $180.2M | 18.4% | $151.5M | 15.5% |
See AHR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AHR vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonAHR — Frequently Asked Questions
Quick answers to the most common questions about buying AHR stock.
Is AHR's revenue growth accelerating or slowing?
AHR maintains +9.4% revenue growth, in line with its 5-year CAGR of +11.1%. TTM revenue stands at $2.2B. Growth rate remains consistent with historical average.
What is AHR's long-term revenue growth rate?
American Healthcare REIT, Inc.'s 5-year revenue CAGR of +11.1% reflects the sustained expansion pattern. Current YoY growth of +9.4% is near this long-term average.
How is AHR's revenue distributed by segment?
AHR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2024 are available for download. Segment mix reveals concentration and diversification trends.